Skip to content
Advertisement

A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London, Oct. 7, 2020. The Novavax COVID-19 vaccine that could soon win federal approval may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the vaccine for religious reasons. (AP Photo/Alastair Grant, File)

A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London, Oct. 7, 2020. The Novavax COVID-19 vaccine that could soon win federal approval may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the vaccine for religious reasons. (AP Photo/Alastair Grant, File)

Featured Photo Galleries